BD Regional Block Needles 22G x 1.50in (50 units/cs.). Indicated for administration of medications to affect anesthesia or analgesia to a specific anatomical location (region). Catalog No. 408348
Check against the official notice below — it lists the full affected range.
Becton Dickinson & Company is recalling BD Regional Block Needles 22G x 1.50in (50 units per case), which are used to administer medications for anesthesia or pain relief to specific body areas. The recall was initiated because the European Notified Body, NSAI, advised that the instructions for use need to be updated to include general contraindications. The affected product was distributed in 18 U.S. states (Alabama, Connecticut, Florida, Illinois, Indiana, Michigan, Missouri, Mississippi, North Carolina, Nebraska, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, and Virginia) as well as Australia, Canada, Belgium, and Singapore. A total of 105,880 units in the U.S. are affected, encompassing all lots within the product's expiration date.
The record does not specify what remedy consumers or healthcare providers should undertake in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
BD was advised by the European Notified Body, NSAI, that the instructions for use (IFU) needs to be updated to include the general contraindications
Reason for recall: BD was advised by the European Notified Body, NSAI, that the instructions for use (IFU) needs to be updated to include the general contraindications Distribution: Alabama, Connecticut, Florida, Illinois, Indiana, Michigan, Missouri, Mississippi, North Carolina, Nebraska, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Virginia. Foreign: Australia, Canada, Belgium and Singapore Quantity: 105880 units US Lot/code info: All lots within expiration date UDI: (01)50382904083484
Official record: FDA (Device enforcement) ↗
Republished from the official source above; details can change — the source record controls.